Corcept Therapeutics EBITDA 2010-2024 | CORT
- Corcept Therapeutics 2023 EBITDA was 0.101B, a 14.43% decline from 2022.
- Corcept Therapeutics 2022 EBITDA was 0.117B, a 11.71% decline from 2021.
- Corcept Therapeutics 2021 EBITDA was 0.133B, a 1.99% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.